Get the Stockscreener App
90.35
0.43%
-0.39
Pre-market:
81.40
-8.95
-9.91%
Disc Medicine Inc stock is traded at $90.35, with a volume of 556.35K.
It is down -0.43% in the last 24 hours and up +3.65% over the past month.
Disc Medicine Inc is a clinical-stage biopharmaceutical company focused on the discovery, development, and commercialization of novel treatments for hematologic diseases. It aims to modify fundamental biological pathways associated with the formation and function of red blood cells, specifically heme biosynthesis and iron homeostasis. Its pipeline includes bitopertin for erythropoietic porphyrias (EPs) including erythropoietic protoporphyria (EPP), X-linked protoporphyria (XLP), and Diamond-Blackfan Anemia (DBA); DISC-0974 for the treatment of anemia of myelofibrosis (MF) and anemia of chronic kidney disease (CKD); and DISC-3405 for the treatment of polycythemia vera (PV) and other hematologic disorders. In addition, the Company's preclinical programs include DISC-0998.
See More
Previous Close:
$90.74
Open:
$92.1
24h Volume:
556.35K
Relative Volume:
1.26
Market Cap:
$3.14B
Revenue:
-
Net Income/Loss:
$-91.00M
P/E Ratio:
-24.62
EPS:
-3.67
Net Cash Flow:
$-74.38M
1W Performance:
+3.80%
1M Performance:
+3.65%
6M Performance:
+80.41%
1Y Performance:
+44.44%
1-Day Range:
$89.80
$94.40
1-Week Range:
$86.93
$94.40
52-Week Range:
$30.82
$95.95
Disc Medicine Inc Stock (IRON) Company Profile
Name
Disc Medicine Inc
Sector
Industry
Phone
(617) 674-9274
Address
321 ARSENAL STREET, SUITE 101, WATERTOWN
Compare IRON with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
IRON
Disc Medicine Inc
|
90.35 | 3.43B | 0 | -91.00M | -74.38M | -3.67 |
|
VRTX
Vertex Pharmaceuticals Inc
|
422.32 | 106.82B | 11.74B | 3.68B | 3.34B | 14.19 |
|
REGN
Regeneron Pharmaceuticals Inc
|
737.00 | 73.86B | 14.25B | 4.58B | 3.88B | 41.77 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
445.79 | 60.87B | 3.21B | 43.57M | 221.36M | 0.2405 |
|
ARGX
Argen X Se Adr
|
918.50 | 56.31B | 3.06B | 1.28B | 447.35M | 19.67 |
|
INSM
Insmed Inc
|
199.64 | 43.41B | 447.02M | -1.18B | -906.14M | -6.1812 |
Disc Medicine Inc Stock (IRON) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Nov-03-25 | Resumed | Stifel | Buy |
| Jul-21-25 | Initiated | Truist | Buy |
| Jul-03-25 | Resumed | Morgan Stanley | Overweight |
| Jun-11-25 | Resumed | Raymond James | Strong Buy |
| Feb-27-25 | Initiated | TD Cowen | Buy |
| Nov-05-24 | Upgrade | Morgan Stanley | Equal-Weight → Overweight |
| Nov-04-24 | Upgrade | Raymond James | Outperform → Strong Buy |
| Oct-23-24 | Initiated | Jefferies | Buy |
| Oct-16-24 | Initiated | Scotiabank | Sector Outperform |
| Aug-22-24 | Initiated | Wells Fargo | Overweight |
| Apr-01-24 | Downgrade | Raymond James | Strong Buy → Outperform |
| Dec-19-23 | Downgrade | Morgan Stanley | Overweight → Equal-Weight |
| Jun-09-23 | Upgrade | Raymond James | Outperform → Strong Buy |
| Jun-07-23 | Initiated | H.C. Wainwright | Buy |
| May-17-23 | Initiated | Raymond James | Outperform |
| Apr-28-23 | Initiated | Cantor Fitzgerald | Overweight |
| Apr-21-23 | Initiated | Stifel | Buy |
| Apr-20-23 | Initiated | Morgan Stanley | Overweight |
| Mar-23-23 | Initiated | BMO Capital Markets | Outperform |
| Feb-28-23 | Initiated | SVB Securities | Outperform |
View All
Disc Medicine Inc Stock (IRON) Latest News
How Disc Medicine Inc. stock performs in high volatility marketsJuly 2025 Short Interest & AI Enhanced Execution Alerts - newser.com
Jefferies reiterates Buy rating on Disc Medicine stock ahead of key catalysts - Investing.com Canada
What technical charts say about Disc Medicine Inc. stockWeekly Investment Summary & Risk Adjusted Buy/Sell Alerts - newser.com
Is Disc Medicine Inc. stock attractive for passive investorsGap Up & Weekly High Conviction Ideas - newser.com
How sustainable is Disc Medicine Inc. stock dividend payout2025 Big Picture & Safe Capital Growth Trade Ideas - newser.com
Disc Medicine Inc. stock momentum explainedPortfolio Return Summary & Fast Gaining Stock Strategy Reports - newser.com
Portfolio Adjustment: Institutional Heavyweight Exits Biotech Stock - AOL.com
Will Disc Medicine Inc. stock recover faster than marketTrade Volume Summary & Growth Focused Investment Plans - newser.com
What makes Disc Medicine Inc. stock attractive to growth fundsWatch List & Real-Time Volume Trigger Notifications - newser.com
Disc Medicine, Inc. $IRON Shares Sold by Patient Square Capital LP - MarketBeat
Can Disc Medicine Inc. stock weather global recessionJuly 2025 Momentum & Technical Pattern Based Signals - newser.com
Bank of Montreal Can Purchases 5,137 Shares of Disc Medicine, Inc. $IRON - MarketBeat
How to escape a deep drawdown in Disc Medicine Inc.Weekly Gains Report & Community Consensus Trade Alerts - newser.com
Is Disc Medicine Inc. stock in correction or buying zoneJuly 2025 Decliners & Growth Oriented Trading Recommendations - newser.com
Insider Selling: Disc Medicine (NASDAQ:IRON) COO Sells 30,000 Shares of Stock - MarketBeat
Does Disc Medicine Inc. stock trade at a discount to peersTrade Risk Assessment & Risk Managed Investment Entry Signals - Fundação Cultural do Pará
Disc Medicine Insider Sold Shares Worth $2,540,923, According to a Recent SEC Filing - MarketScreener
Yu Jonathan, Disc Medicine COO, sells $2.54 million in iron stock - Investing.com Australia
Is Disc Medicine Inc. stock trading near support levelsTrade Volume Summary & Technical Pattern Based Signals - newser.com
Disc Medicine Inc Stock (IRON) Financials Data
Revenue
Net Income
Cash Flow
EPS
Disc Medicine Inc Stock (IRON) Insider Trading
| Insider Trading | Relationship | Date | Transaction | Cost | #Shares | Value ($) | #Shares Total |
|---|---|---|---|---|---|---|---|
| Yu Jonathan Yen-Wen | Chief Operating Officer |
Nov 11 '25 |
Sale |
84.70 |
30,000 |
2,540,923 |
40,555 |
0.67%
0.43%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):